Three Catalysts That Are Transforming Oncology

How to combine scientific communications and technology to unlock new possibilities and accelerate the pace of progress

The oncology market is an expanding, yet increasingly noisy environment in which to introduce new therapies. Three catalysts are profoundly affecting it:

1. Personalized medicine
2. Novel targets and drug designs
3. Patient experience data

Each of these presents challenges and opportunities. Hear from OPEN Health’s experts on how to effectively leverage technology and communications to ensure your therapy resonates in the market.

• Hear from patient storytelling leader Jasmine Malone on how to bridge the knowledge gaps between HCPs, patients and advocacy groups.
• Understand the importance of aligning medical communications plans for multiple products that target different patient populations. Scientific Communications expert Emma Winter outlines an approach to maintaining a cohesive message.
• Chief Technology Officer David Sakadelis explains how AI and technology can amplify human expertise and address the challenge of how to communicate increasingly complex therapies in a busy environment.

Succeeding in the modern oncology space demands a robust strategy across medical, market access and commercial teams. In this whitepaper, OPEN Health shares some of its expertise to help you unlock the benefits of technology and communication.